Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cardiac metabolism is deranged in dilated cardiomyopathy (DCM). Phosphorus-31 (31P) and hydrogen-1 (1H) magnetic resonance spectroscopy (MRS) allow for the non-invasive assessment of various aspects of cardiac metabolism, showing deranged cardiac energetics and lipid accumulation in DCM. In the future, MRS may become an important biomarker tool for monitoring the effects of novel heart-failure treatments in DCM.


Journal article


Heart and Metabolism

Publication Date



13 - 16